Stem Cell Therapy for Autoimmune Diseases

Stem Cell Therapy for Autoimmune Diseases

Millions of people suffer from autoimmune diseases. ‘Autoimmune diseases’ are a wide range of conditions that involves the body’s healthy cells being attacked by its own immune system.

Autoimmune diseases significantly alter the patient’s quality of life and are not curable. The damage to healthy cells negatively impacts many aspects of physical well-being. It can also cause pain, discomfort, immobility, and visible changes in a person’s appearance.

Currently, the treatment for majority of autoimmune diseases is done with medications, mainly steroids. This results in several side effects in addition to the symptoms.

Fortunately, stem cell therapy holds great potential in the treatment of autoimmune diseases and related symptoms.

Stem cells therapy and autoimmune diseases

Stem Cell treatment focuses on areas of damage to restore regeneration of healthy cells. This helps to alleviate symptoms and reverse tissue damage in autoimmune diseases.

Adipose or fat derived adult stem cells possess the ability to reset the immune system, improve cell-to-cell communication in restoring the body to its natural state of balance and reduce inflammation. These stem cells are harvested from the patient’s own fat tissue.

Stem cell treatments have given new hope to patients whose life is greatly impacted by the effects of autoimmune diseases and the side effects of medications used to treat their symptoms. The effects of stem cell therapy are often felt quickly and patients are able to live pain-free and move more with reduced risk of organ failure.

To learn more about adipose or fat derived stem cell therapy and stromal vascular fraction, call the leading Chicago stem cell treatment center, The Regenerative Stem Cell Institute at 855-340-7836 Now. The Regenerative Stem Cell Institute specializes in the use of adipose (fat) derived stem cells to advance successful outcomes and quality care in the area of regenerative medicine.

No Comments

Sorry, the comment form is closed at this time.